Consensus Target
High Target
Median Target
Low Target
| Date | Analyst | Company | Price Target | News Title |
|---|---|---|---|---|
| 2022-12-01 | N/A | H.C. Wainwright | $21 | HC Wainwright & Co. Maintains Buy on Portage Biotech, Lowers Price Target to $21 |
| 2022-11-30 | N/A | Oppenheimer | $18 | Oppenheimer Maintains Outperform on Portage Biotech, Lowers Price Target to $18 |